13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001442273
Total reported value
$153.1M
$153.1M
58 檔
34.9%
At the close of Q4 2025, Act Capital Management, LLC disclosed equity holdings valued at approximately $153.1M, spread across 58 reported holdings.
In Q4 2025, Act Capital Management, LLC adopted a defensive or profit-taking posture, trimming 4 positions and completely liquidating 108 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | KRYS | Krystal Biotech Inc | Stock-Healthcare | 12.06% | -1.35% | +3.77% | |
| 2 | CVX | Chevron CORP | Stock-Energy | 9.67% | -4.08% | +248.89% | |
| 3 | XOM | Exxon Mobil CORP | Stock-Energy | 8.03% | -2.32% | +1.10% | |
| 4 | ABVX | Abivax Sa-adr | Stock-Other | 6.97% | +2.24% | — | |
| 5 | TGTX | Tg Therapeutics Inc | Stock-Healthcare | 6.48% | +2.51% | — | |
| 6 | VKTX | Viking Therapeutics Inc | Stock-Healthcare | 5.86% | -0.02% | — | |
| 7 | CELC | Celcuity Inc | Stock-Other | 5.11% | -3.97% | — | |
| 8 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 4.59% | -3.39% | — | |
| 9 | NUVB | Nuvation Bio Inc | Stock-Other | 4.42% | +0.95% | — | |
| 10 | ARWR | Arrowhead Pharmaceuticals In | Stock-Healthcare | 4.03% | +1.79% | -32.13% | |
| 11 | CYTK | Cytokinetics Inc | Stock-Healthcare | 3.31% | -0.70% | — | |
| 12 | ✓ | Celcuity Inc Com Mar 20 26 $50 Call (celc) | Stock-Other | 2.46% | — | — | |
| 13 | GPCR | Structure Therapeutics Inc | Stock-Other | 2.17% | — | — | |
| 14 | GBTC | Grayscale Bitcoin Trust ETF | ETF-Crypto | 1.90% | -0.18% | — | |
| 15 | FIGR | Figure Technology Solut-cl A | Stock-Other | 1.90% | — | — | |
| 16 | SPOT | Spotify Technology S.A. | Stock-Comm Services | 1.88% | — | — | |
| 17 | ET | Energy Transfer LP | Stock-Energy | 1.77% | -0.36% | +4.15% | |
| 18 | NKTR | Nektar Therapeutics | Stock-Other | 1.75% | +0.06% | — | |
| 19 | OLMA | Olema Pharmaceuticals Inc | Stock-Other | 1.08% | -0.29% | EXIT | |
| 20 | IBM | Intl Business Machines CORP | Stock-Tech | 1.08% | — | — | |
| 21 | STAA | Staar Surgical Co | Stock-Other | 1.04% | -0.82% | EXIT | |
| 22 | ✓ | Stock-Other | 1.01% | — | — | ||
| 23 | RGNX | Regenxbio Inc | Stock-Other | 0.96% | +0.16% | — | |
| 24 | BE | Bloom Energy Corp- A | Stock-Industrials | 0.91% | +1.00% | — | |
| 25 | HCC | Warrior Met Coal Inc | Stock-Materials | 0.86% | -0.12% | — | |
| 26 | EOG | Eog Resources Inc | Stock-Energy | 0.85% | — | — | |
| 27 | SNDK | Sandisk CORP | Stock-Tech | 0.67% | — | — | |
| 28 | DVN | Devon Energy CORP | Stock-Energy | 0.65% | — | -73.33% | |
| 29 | PATH | Uipath Inc - Class A | Stock-Tech | 0.62% | -0.23% | — | |
| 30 | KURA | Kura Oncology Inc | Stock-Other | 0.62% | +0.17% | — | |
| 31 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 0.58% | — | — | |
| 32 | REPL | Replimune Group Inc | Stock-Other | 0.48% | -0.37% | EXIT | |
| 33 | SRRK | Scholar Rock Holding CORP | Stock-Other | 0.43% | -0.20% | — | |
| 34 | APGE | Apogee Therapeutics Inc | Stock-Other | 0.43% | — | — | |
| 35 | CRGY | Crescent Energy Inc-a | Stock-Energy | 0.42% | -0.19% | — | |
| 36 | WGS | Genedx Holdings CORP | Stock-Other | 0.32% | -0.22% | — | |
| 37 | PALI | Palisade Bio Inc | Stock-Other | 0.29% | +0.07% | — | |
| 38 | ACOG | Alpha Cognition Inc | Stock-Other | 0.27% | +0.02% | — | |
| 39 | LQDA | Liquidia CORP | Stock-Other | 0.24% | — | — | |
| 40 | KYTX | Kyverna Therapeutics Inc | Stock-Other | 0.19% | +0.03% | — | |
| 41 | BW | Babcock & Wilcox Enterpr | Stock-Other | 0.19% | — | — | |
| 42 | ALDX | Aldeyra Therapeutics Inc | Stock-Other | 0.17% | — | — | |
| 43 | ✓ | Stock-Other | 0.17% | -0.02% | — | ||
| 44 | PRAX | Praxis Precision Medicines I | Stock-Other | 0.17% | -0.09% | — | |
| 45 | ESPR | Esperion Therapeutics Inc | Stock-Other | 0.14% | -0.10% | EXIT | |
| 46 | LSPD | Lightspeed Commerce Inc | Stock-Other | 0.12% | — | — | |
| 47 | DAWNGBX | Day One Biopharmaceuticals I | Stock-Other | 0.10% | — | — | |
| 48 | TVTX | Travere Therapeutics Inc | Stock-Other | 0.09% | — | — | |
| 49 | AMLX | Amylyx Pharmaceuticals Inc | Stock-Other | 0.09% | -0.10% | EXIT | |
| 50 | WY | Weyerhaeuser Co | Stock-Real Estate | 0.09% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | KRYS | Krystal Biotech Inc | +11.4% | +3.77% | Add |
| 2 | VKTX | Viking Therapeutics Inc | +5.5% | — | Add |
| 3 | TGTX | Tg Therapeutics Inc | +5.4% | — | Add |
| 4 | AMZN | Amazon.com Inc | +4.2% | — | Add |
| 5 | ALDX | Aldeyra Therapeutics Inc | +0.2% | — | Add |
| 6 | YALA | Yalla Group LTD | -0.1% | -62.96% | Trim |
| 7 | PDSB | Pds Biotechnology CORP | -0.3% | +150.00% | Trim |
| 8 | ARWR | Arrowhead Pharmaceuticals In | -4.9% | -32.13% | Trim |
| 9 | STAA | Staar Surgical Co | -17.1% | -75.09% | Trim |
| 10 | ARCT | Arcturus Therapeutics Holdin | — | EXIT | Sold out |
| 11 | CLSDUSD | Clearside Biomedical Inc | — | EXIT | Sold out |
| 12 | CVX | Chevron CORP | — | NEW | New buy |
| 13 | XOM | Exxon Mobil CORP | — | NEW | New buy |
| 14 | ABVX | Abivax Sa-adr | — | NEW | New buy |
| 15 | FUBOGBP | Fubotv Inc | — | EXIT | Sold out |
| 16 | ✓ | Aspira Women's Health Inc | — | EXIT | Sold out |
| 17 | CELC | Celcuity Inc | — | NEW | New buy |
| 18 | NUVB | Nuvation Bio Inc | — | NEW | New buy |
| 19 | TREUR | Trillium Therapeutics Inc | — | EXIT | Sold out |
| 20 | CYTK | Cytokinetics Inc | — | NEW | New buy |
| 21 | FLNA | Filana Therapeutics Inc | — | EXIT | Sold out |
| 22 | ICADUSD | Icad Inc | — | EXIT | Sold out |
| 23 | U | Unity Software Inc | — | EXIT | Sold out |
| 24 | UPST | Upstart Holdings Inc | — | EXIT | Sold out |
| 25 | ✓ | Celcuity Inc Com Mar 20 26 $50 Call (celc) | — | NEW | New buy |
| 26 | NTRA | Natera Inc | — | EXIT | Sold out |
| 27 | SKIN | Skinhealth Systems Inc | — | EXIT | Sold out |
| 28 | NKTREUR | Nektar Therapeutics | — | EXIT | Sold out |
| 29 | FFIV | F5 Inc | — | EXIT | Sold out |
| 30 | GPCR | Structure Therapeutics Inc | — | NEW | New buy |
| 31 | IKTEUR | Inhibikase Therapeutics Inc | — | EXIT | Sold out |
| 32 | AFRM | Affirm Holdings, Inc. | — | EXIT | Sold out |
| 33 | GBTC | Grayscale Bitcoin Trust ETF | — | NEW | New buy |
| 34 | FIGR | Figure Technology Solut-cl A | — | NEW | New buy |
| 35 | SPOT | Spotify Technology S.A. | — | NEW | New buy |
| 36 | ✓ | Neoleukin Therapeutics Inc | — | EXIT | Sold out |
| 37 | ET | Energy Transfer LP | — | NEW | New buy |
| 38 | NVAX | Novavax Inc | — | EXIT | Sold out |
| 39 | NKTR | Nektar Therapeutics | — | NEW | New buy |
| 40 | INMD | InMode Ltd. | — | EXIT | Sold out |
| 41 | AUPH | Aurinia Pharmaceuticals Inc | — | EXIT | Sold out |
| 42 | NUANEUR | Nuance Communications Inc | — | EXIT | Sold out |
| 43 | ✓ | Myovant Sciences LTD | — | EXIT | Sold out |
| 44 | ✓ | — | EXIT | Sold out | |
| 45 | UTHR | United Therapeutics CORP | — | EXIT | Sold out |
| 46 | ATRAGBX | Atara Biotherapeutics Inc | — | EXIT | Sold out |
| 47 | RETAEUR | Reata Pharmaceuticals Inc-a | — | EXIT | Sold out |
| 48 | GTXIEUR | Oncternal Therapeutics Inc | — | EXIT | Sold out |
| 49 | ✓ | Gores Holdings Vi Inc | — | EXIT | Sold out |
| 50 | IDYA | Ideaya Biosciences Inc | — | EXIT | Sold out |
According to official SEC Form 13F filings, Act Capital Management, LLC reported a total U.S. public equity portfolio value of $153.1M across 58 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including KRYS, CVX, XOM) accounted for 34.9% of total reported equity market value during Q4 2025.
Top New Position Initiated
CVX
市值: $12.0M
Top Position Liquidated / Trimmed
ARCT
前期市值: $15.4M
During Q4 2025, Act Capital Management, LLC's top holdings by market value included KRYS (12.1%)、CVX (9.7%)、XOM (8.0%). The largest single position, KRYS, represented 12.1% of total portfolio value.
In Q4 2025, Act Capital Management, LLC made 166 total portfolio adjustments, initiating 49 new buys, adding to 5 positions, trimming 4 holdings, and fully liquidating 108 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.